Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation

BACKGROUND: 3-Hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) have been widely used to reduce cardiovascular risk. These statins (i.e., simvastatin) may exert other effects besides from their cholesterol-lowering actions, including inhibition of platelet activation. Pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ye-Ming, Chen, Wei-Fan, Chou, Duen-Suey, Jayakumar, Thanasekaran, Hou, Ssu-Yu, Lee, Jie-Jen, Hsiao, George, Sheu, Joen-Rong
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894762/
https://www.ncbi.nlm.nih.gov/pubmed/20525309
http://dx.doi.org/10.1186/1423-0127-17-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894762/
https://www.ncbi.nlm.nih.gov/pubmed/20525309
http://dx.doi.org/10.1186/1423-0127-17-45

Ejemplares similares